| Naslov: | Fibulin-3 in plasma and pleural effusion as a biomarker of mesothelioma |
|---|
| Avtorji: | ID Adamič, Katja, Univerzitetna klinika za pljučne bolezni in alergijo Golnik (Avtor)
ID Marc-Malovrh, Mateja, Univerzitetna klinika za pljučne bolezni in alergijo Golnik (Avtor)
ID Bidovec, Urška, Univerzitetna klinika za pljučne bolezni in alergijo Golnik (Avtor)
ID Rozman, Aleš, Univerzitetna klinika za pljučne bolezni in alergijo Golnik (Avtor) |
|---|
| Datoteke: |  URL - Izvorni URL, za dostop obiščite https://radioloncol.com/index.php/ro/article/view/4562/5307
 PDF - Predstavitvena datoteka, prenos (500,53 KB)
MD5: D02F37BCC235D704C309DBEEA35D6667
|
|---|
| Jezik: | Angleški jezik |
|---|
| Tipologija: | 1.01 - Izvirni znanstveni članek |
|---|
| Organizacija: |  UKPBAG - Univerzitetna klinika za pljučne bolezni in alergijo Golnik
|
|---|
| Povzetek: | Background: Malignant pleural mesothelioma (MPM) is a global health concern linked to asbestos exposure. In Slovenia, regions with high asbestos exposure rates make MPM a significant public health issue. Although thoracoscopic biopsy is the gold standard for MPM diagnosis, its invasiveness highlights the need for reliable, non-invasive diagnostic biomarkers. Patients and Methods: This prospective study evaluated the diagnostic potential of fibulin-3 as a biomarker for MPM, focusing on its ability to distinguish MPM from other pleural conditions, its association with disease stage and histological subtype, and its prognostic value for survival. 90 patients who underwent diagnostic thoracoscopic biopsy from January 2013 to October 2014 were included. Fibulin-3 levels in plasma and pleural effusion were measured using ELISA, and clinical data were analysed with statistical tests, including ROC analysis. Results: The study cohort comprised 32 patients with MPM, 24 with metastatic pleural carcinoma, and 34 with benign pleural diseases. Plasma fibulin-3 levels were significantly elevated (p = 0.0132) in MPM patients compared to those with benign pleural effusions due to asbestos exposure, with a cut-off of 12.31 ng/mL showing 100% specificity but low sensitivity (39.39%). Elevated fibulin-3 levels in pleural effusion correlated with advanced disease (p = 0.0463) and aggressive histological subtypes (p = 0.0324). No significant survival correlation was observed. Conclusions: While plasma fibulin-3 is a highly specific biomarker for MPM, its low sensitivity limits its standalone diagnostic utility. Its potential role in risk stratification and early detection in at-risk populations warrants further study. |
|---|
| Ključne besede: | fibulin-3, asbestos, pleural effusion, mesothelioma, biomarker |
|---|
| Status publikacije: | Objavljeno |
|---|
| Verzija publikacije: | Objavljena publikacija |
|---|
| Poslano v recenzijo: | 30.12.2024 |
|---|
| Datum sprejetja članka: | 19.01.2025 |
|---|
| Datum objave: | 12.06.2025 |
|---|
| Založnik: | Association of Radiology and Oncology |
|---|
| Leto izida: | 2025 |
|---|
| Št. strani: | str. 225-232 |
|---|
| Številčenje: | Vol. 59, no. 2 |
|---|
| Izvor: | Radiology and oncology |
|---|
| PID: | 20.500.12556/DiRROS-22707  |
|---|
| UDK: | 616-006.3.04(497.4) |
|---|
| ISSN pri članku: | 1581-3207 |
|---|
| DOI: | 10.2478/raon-2025-0024 |
|---|
| COBISS.SI-ID: | 239473667 |
|---|
| Avtorske pravice: | This journal provides immediate open access to its content under the Creative Commons CC BY 4.0 license. Authors who publish with this journal retain all copyrights and agree to the terms of the above-mentioned CC license. |
|---|
| Opomba: | Nasl. z nasl. zaslona;
Soavtorji: Mateja Marc Malovrh, Urška Bidovec Stojković, Aleš Rozman;
Opis vira z dne 16. 6. 2025;
|
|---|
| Datum objave v DiRROS: | 18.06.2025 |
|---|
| Število ogledov: | 428 |
|---|
| Število prenosov: | 220 |
|---|
| Metapodatki: |    |
|---|
|
:
|
Kopiraj citat |
|---|
| | | | Objavi na: |  |
|---|
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše
podrobnosti ali sproži prenos. |
